Market closed today (Weekend) · Prices and yields as of last trading day, 06 Nov 2026
Happy Diwali from all of us at RetailBonds

Matrix Pharmacorp Private Limited — Bonds

Corporate · Healthcare

Verify this issuer →
Methodology v1.0 Download Report (PDF) Watch
Agency Rating
AA-
Rating on NSDL record (CRISIL, 2024)
No current agency rating on file
Total Debt Outstanding
₹1,645 Cr
Across 3 instruments
Active Bonds
3
First Issue
31 May 2024
Latest Issue
3 Jun 2024
Maturity Range
2028 - 2035
Observation
3 active bonds tracked from this issuer.
View details →
Coverage: Medium Data Quality: Medium Sources: NSE, BSE, SEBI, rating agencies

Latest events

Last 90 days · company disclosures to the exchanges and agency announcements. Not our assessment.
  • 30 Oct 2026 New rating assigned to A1+ CRISIL
Issuer health card 1 item to look at
  • Current ratings No current agency rating on file; NSDL's debt master records a rating for some bonds, often from the time of issue
  • Rating direction, 12 months 0 upgrades, 0 downgrades
  • Watch / negative outlook None in 12 months
  • Issuer not cooperating No such actions in 12 months
  • Rating withdrawn, 12 months No withdrawal of this issuer's rating in 12 months
  • Newest agency rating Dated 30 Oct 2026
  • Payment record No payment disclosures since 17 Jul 2026
  • Defaults on record No bond marked defaulted
  • Traded in the last 30 days 0 of 3 active bonds had an exchange trade
  • Exchange filings, 90 days 0 filings on NSE/BSE

A checklist of published facts, not a rating or a view on credit quality. Ratings are the agencies' own; payment record covers NSE disclosures since 17 Jul 2026; "late" means paid more than 3 days after the due date (next-working-day payments are allowed). Rating range covers every current rating on the issuer's active bonds, with each agency's rating date. Rating actions count only when the agency's heading names this issuer, not pools or trusts it originated; a withdrawal is flagged only when the issuer's rating itself is withdrawn, not a single facility. Rating age uses the newest rating date on file and is flagged when older than 12 months. See methodology.

Alert me about Matrix Pharmacorp Private Limited An email when a rating agency acts on this issuer (including any cut to default grade D) or a payment is disclosed late or short. Free, no account needed.
01 Issuer Overview
Sector
Healthcare
Issuer Type
Corporate
First Tracked Bond
31 May 2024
Start of this issuer's debt program timeline
  • 3 active bonds tracked from this issuer.
  • 2 of 3 tracked bonds with a stated security status are secured. (based on 3 bonds with a disclosed security status)
  • Most recent rating action: initial by CRISIL on 30 Oct 2026.

Matrix Pharmacorp Private Limited is a corporate issuer in the Healthcare sector. Coupon rates on outstanding bonds range from 6.00% - 11.95%, paid quarterly. Bonds mature between 2028 - 2035.

Data sourced from NSDL, BSE, NSE, and registered credit rating agencies. Verify against the issuer's offer document before transacting.

Thanks — your suggestion has been submitted for review.

02 Debt Profile
Outstanding Bonds
3
Tracked by RetailBonds
Amount Tracked
₹1,645 Cr
Of bonds tracked by RetailBonds — not the issuer's total outstanding debt
Avg Coupon
9.32%
Range 6.00% - 11.95%
Avg Remaining Tenure
4.4 Yrs
Nearest maturity Nov 2028
Secured
66%
2 of 3 bonds with known status
Callable
2
Of 3 bonds

Maturity Profile

Active bonds maturing, by year. Bar height relative to the tallest year (1 bond).

0 2028: 1 bond, ₹615 Cr tracked, avg coupon 10.00% 1 bond 2028 2029: 1 bond, ₹200 Cr tracked, avg coupon 11.95% 1 bond 2029 2035: 1 bond, ₹830 Cr tracked, avg coupon 6.00% 1 bond 2035

Security Type / Instrument Mix

  • NCD 3 bonds · 100% · ₹1,645 Cr tracked

Funding Evolution

■ Issued that year — Cumulative outstanding (tracked)
2024: ₹1,645 Cr issued 2024 Cumulative: ₹1,645 Cr

Based on 3 of 3 active bonds with a known issue date and issue size.

03 Credit Profile
  • AA 2 bonds · 67%
  • Unrated 1 bond · 33%
AgencyRatingOutlookBonds
CRISIL AA- NSDL record — 2

Recent Rating Actions

30 Oct 2026 · CRISIL
A1+
Initial
04 Outstanding Bonds View all bonds →
ISIN Bond Name Coupon Rating Maturity YTM Last Trade Details
INE0U0U07035 Matrix Pharmacorp 10.00% Nov 2028 NCD 10.00% AA- (CRISIL, NSDL record 2024) 2028-11-30 — —
INE0U0U07019 Matrix Pharmacorp 11.95% May 2029 NCD 11.95% AA- (CRISIL, NSDL record 2024) 2029-05-31 — —
INE0U0U08017 Matrix Pharmacorp 6.00% Jun 2035 CCD 6.00% — 2035-06-03 — —
Compare (/) Compare Bonds

YTM is the market yield from the latest BSE/NSE trade. It shows “—” when that trade is over 30 days old, the bond is under 30 days from maturity, it is a market-linked debenture, or the price failed our checks (hover the dash for the reason). A coupon is never shown as a yield.

05 Market Activity

No recorded secondary-market trades in the last 30 days.

06 Regulatory Filings
Credit Rating Rationale
07 Methodology & Data Coverage
DatasetCountFreshness
Credit Ratings (current) 2 2024-04-26
Rating Actions History 1 2026-10-30
Secondary-Market Trades 0 —
Reg52(4) Payment Disclosures 0 —

Methodology version 1.0. See full methodology for sources and limitations.

Related Issuers

All issuers →
Frequently Asked Questions
How many active bonds does Matrix Pharmacorp Private Limited have?

Matrix Pharmacorp Private Limited currently has 3 active bonds with coupons of 6.00% - 11.95%, maturities spanning 2028 - 2035.

Are Matrix Pharmacorp Private Limited's bonds secured?

Of the 3 bonds with a disclosed security status, 2 are secured (66%) and 1 is unsecured.

When do Matrix Pharmacorp Private Limited's bonds mature?

Matrix Pharmacorp Private Limited's active bonds mature between 2028 - 2035; the nearest matures in Nov 2028; the average tenure is 4.4 Yrs.

What is the average coupon on Matrix Pharmacorp Private Limited's bonds?

The average coupon across Matrix Pharmacorp Private Limited's 3 active bonds is 9.32%.

Disclaimer: This page aggregates publicly available data about Matrix Pharmacorp Private Limited for informational purposes only. Ratings shown are the opinion of the issuing rating agency and are not buy/sell recommendations. RetailBonds.in does not issue its own ratings or investment advice. Verify all data against the issuer’s offer document before transacting.